
A weekly publication by the Bureau of Epidemiology
August 17, 2001"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Steven T. Wiersma, MD, MPH—Acting Bureau Chief and State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Bureau of Epidemiology Frequent Contributors:
|
Kathryn Snavely, MPH Reportable Disease Manager |
Jodi Baldy, MPH, Biological Scientist IV |
|
Ursula E. Bauer, PhD, Chronic Disease Epidemiologist |
Lisa Conti, DVM, MPH, State Public Health Veterinarian |
Regional Epidemiologists:
|
Dolly Katz, PhD, MPH, SE Florida |
Roger Sanderson, RN, MA, SW Florida |
Carina Blackmore, MS Vet. Med., PhD, NE Florida |
Zuber Mulla, PhD MSPH, Central Florida Carina Blackmore, MS Vet. Med., PhD, |
Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.
The Department of Health has a home on the World Wide Web at
http://www.doh.state.fl.usFor information on diseases and conditions of public health importance go to
MyFlorida.com, click on Health and Human Services, then Consumers--Diseases and Conditions.In this Issue:
Steven T. Wiersma, Acting Chief, Bureau of Epidemiology and State Epidemiologist
FOR IMMEDIATE RELEASE August 17, 2001
CONTACT: Frank Penela 1-850-245-4111/ 850-933-0375 (cell phone)
Carina Blackmore, DVM, PhD 1-877-631-5445 (toll-free pager)
Steven Wiersma MD, MPH 1-877-210-5031 (toll-free pager)
*** MOSQUITO-BORNE VIRUS UPDATE***
Florida’s Second Human Case of Eastern Equine Encephalitis Confirmed
Medical Alert Extended to 30 Counties with Addition of Levy County
TALLAHASSEE—The Florida Department of Health (DOH) announced today that the second human encephalitis case caused by the Eastern equine encephalitis (EEE) virus has been confirmed. The case was reported in a 39-year-old male who was most likely exposed to the disease in Levy County. There have been two confirmed human cases of WN virus encephalitis and two confirmed cases of Eastern equine encephalitis.
A previous medical alert issued by health officials for EEE and West Nile virus has now been extended to include Levy County. The alert is now in effect for 30 north Florida counties, including: Baker, Bay, Bradford, Calhoun, Clay, Columbia, Duval, Escambia, Franklin, Gadsden, Gulf, Hamilton, Holmes, Jackson, Jefferson, Lafayette, Leon, Levy, Liberty, Madison, Nassau, Okaloosa, Santa Rosa, St. Johns, Suwannee, Taylor, Union, Wakulla, Walton and Washington counties.
The Department of Health urges all Floridians to take precautions against mosquito bites. DOH is recommending the following:
The Department of Health continues to track mosquito-borne viruses in dead birds collected by citizens, through the regular testing of sentinel chickens, through horse test results provided by the Department of Agriculture and Consumer Services, and through reports of human disease from Florida physicians.
Physicians are urged to report all cases of encephalitis and meningitis to their local health department. Laboratory testing by the DOH is available to physicians free-of-charge.
Animal surveillance for WN virus has detected 38 confirmed-positive dead birds, 31 horses, and 3 sentinel chickens all from counties covered by the medical alert. EEE virus surveillance has detected 20 confirmed-positive horses, none of which were reported in Levy county.
For more information on mosquito-borne encephalitis, including reporting human cases and dead birds, visit the DOH Bureau of Epidemiology’s Arboviral Encephalitis and West Nile Virus website at MyFlorida.com (click on Health and Human Services, then Consumers – Diseases and Conditions, then Arboviral Encephalitis) or
http://www.doh.state.fl.us/disease_ctrl/epi/htopics/arbo/index.htm, or call the Bureau’s hotline at 1-888-880-5782 for recorded information.###
2. Grand Rounds Tuesday August 28, 2001
Melanie Black, MSW, Professional Training Coordinator, Bureau of Epidemiology
"Invasive Group A Streptococcal Infections in Florida: Risk Factors for Hospital Mortality"Zuber D. Mulla, MSPH 1,2; Paul E. Leaverton, PhD 1, Steven T. Wiersma, MD, MPH 2
11:00 AM – 12:00 PM EST
Dial-in by 11:10 AM at (850) 487-8587 or SunCom 277-8587
Abstract
Group A Streptococcus can cause serious infections such as necrotizing fasciitis, septicemia, and toxic shock syndrome. Several previous studies of invasive group A streptococcal disease had small sample sizes (£ 100 patients) and only included patients from one or two hospitals. We conducted a population-based study of invasive group A streptococcal disease in Florida. The objectives of the study were to describe the clinical features of individuals who were hospitalized for invasive group A streptococcal disease and to identify risk factors for hospital mortality. The cases were 257 patients who were hospitalized throughout Florida between August of 1996 and August of 2000 and were reported to the Florida Department of Health’s Bureau of Epidemiology.
Skin was the most common focus of infection. Twenty-two percent of the cases had primary bacteremia (57/256). Multiple logistic regression was used to calculate adjusted odds ratios (AOR) for hospital mortality and 95% confidence intervals (CI). A total of 195 patient records were included in the multivariate analyses. Admission into an intensive care unit was a strong predictor of mortality (AOR=20.41, 95% CI: 6.41-64.96). Risk of mortality increased with age. Treatment with clindamycin protected against mortality in patients who had necrotizing fasciitis (AOR=0.11, 95% CI: 0.01-0.89) but not in patients who did not have necrotizing fasciitis (AOR=1.01, 95% CI: 0.31-3.33).
Additional Information
Further details regarding the audio-conference call and PowerPoint files will be posted on the Bureau of Epidemiology Intranet web site
. Be sure and register online at the end of the program to obtain nursing CEU’s and laboratory contact hours for this program. Information about upcoming topics and presenters will also be posted in the Epi Update. If either of these access points is unavailable to you, please email Melanie Black [Melanie_Black@doh.state.fl.us] or telephone (850) 245-4444 ext. 2448 (SunCom 205-4444 ext. 2448) to request presentation materials.Important
While we realize you might not always be able to call in at 11:00 AM, it can be distracting to the speaker and others in the audience when participants dial-in throughout the hour. Please try to call in on time and remember to put your phones on mute so as not to disturb others. Thank you for your cooperation.
3. Hepatitis Extended Data--No Need for Sending Hard Copies
Kathryn Snavely, MPH, Reportable Disease Manager
The Bureau of Epidemiology is no longer accepting paper hepatitis case report forms from county health departments. With the extended data screens in place we are able to collect data electronically, eliminating the need for county health departments to send in paper Acute Viral Hepatitis forms. All the necessary data fields for the CDC NETSS weekly transmission, which were previously manually entered from paper forms, are gathered from the Merlin extended data screens. All changes to the extended data screens can be done at any time and the case will be flagged as an update.
4. Proposed New Malaria Case Report Form
Don Ward, Surveillance Section Administrator
In January, we provided county health department epidemiology programs with a proposed (CDC) new case report form for malaria. We asked for a trial use of the form and for comments regarding its utility. We received a number of comments and suggestions, which we have forwarded to the malaria program staff at CDC. The CDC staff are currently revising the form, and intend to have an updated version available later in the fall. We are now asking that the use of the test version be discontinued and county health departments return to the use of the previous standard form. Thank you all for your comments and recommendations; I know that CDC appreciates your efforts.
5. Weekly Disease Table (Week 32)
| DISEASE |
1999 TO |
2000 TO |
3-YEAR |
2000 |
2001 TO |
2001 |
|
Animal Rabies |
114 |
89 |
110 |
161 |
137 |
7 |
|
Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, foodborne |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, infant |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, wound |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, other |
0 |
0 |
0 |
0 |
0 |
0 |
|
Brucellosis |
0 |
2 |
1.3 |
2 |
1 |
0 |
|
Campylobacteriosis |
548 |
574 |
517.7 |
1026 |
538 |
17 |
|
Ciguatera |
2 |
1 |
3 |
14 |
0 |
0 |
|
Cryptosporidiosis |
71 |
48 |
63.7 |
180 |
46 |
2 |
|
Cyclosporiasis |
3 |
6 |
5 |
9 |
27 |
0 |
|
Dengue Fever |
2 |
1 |
1.3 |
3 |
3 |
0 |
|
Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
|
Ehrlichiosis, human |
1 |
0 |
0.3 |
0 |
0 |
0 |
|
Encephalitis, chickenpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
1 |
0 |
|
Encephalitis, herpes |
3 |
3 |
3 |
7 |
1 |
0 |
|
Encephalitis, influenza |
0 |
1 |
0.3 |
1 |
0 |
0 |
|
Encephalitis, measles |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, mumps |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, other |
5 |
6 |
6 |
8 |
2 |
0 |
|
Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Venezuelan |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Western Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Escherichia Coli 0157:H7 |
29 |
43 |
30.7 |
95 |
19 |
0 |
|
Escherichia Coli, other |
12 |
6 |
6.7 |
13 |
9 |
2 |
|
Giardiasis |
606 |
727 |
691.3 |
1466 |
599 |
22 |
|
H. Influenzae Cellulitis |
0 |
0 |
0.7 |
1 |
0 |
0 |
|
H. Influenzae Epiglottitis |
0 |
0 |
0 |
1 |
0 |
0 |
|
H. Influenzae Meningitis |
11 |
3 |
8.3 |
11 |
6 |
0 |
|
H. Influenzae Pneumonia |
3 |
2 |
2.7 |
7 |
12 |
0 |
|
H. Influenzae Prim.Bacteremia |
20 |
23 |
18.7 |
57 |
47 |
1 |
|
H. Influenzae Septic Arthritis |
0 |
0 |
0 |
1 |
0 |
0 |
|
Hantaviris Infection |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hemolytic Uremic Syndrome |
6 |
8 |
6.7 |
18 |
2 |
0 |
|
Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hepatitis A |
381 |
283 |
322 |
589 |
346 |
19 |
|
Hepatitis B |
241 |
269 |
247.7 |
525 |
247 |
12 |
|
Hepatitis B (+HbsAg in pregnant women) |
36 |
241 |
92.3 |
493 |
248 |
12 |
|
Hepatitis, Perinatal Hep B |
1 |
1 |
0.7 |
1 |
4 |
0 |
|
Hepatitis C |
30 |
11 |
13.7 |
19 |
14 |
0 |
|
Hepatitis, Non-A, Non-B |
3 |
5 |
19.7 |
6 |
2 |
0 |
|
Hepatitis, Other, including unspecified |
9 |
6 |
7.3 |
7 |
4 |
0 |
|
Lead Poisoning |
990 |
672 |
907.3 |
1219 |
380 |
7 |
|
Legionellosis |
14 |
25 |
20.3 |
51 |
45 |
3 |
|
Leprosy |
2 |
2 |
2.3 |
4 |
0 |
0 |
|
Leptospirosis |
0 |
1 |
0.7 |
2 |
0 |
0 |
|
Listeriosis |
15 |
17 |
10.7 |
32 |
13 |
0 |
|
Lyme Disease |
14 |
15 |
17.3 |
54 |
15 |
1 |
|
Malaria |
52 |
48 |
45 |
90 |
32 |
2 |
|
Measles |
2 |
1 |
1.7 |
2 |
0 |
0 |
|
Meningitis, Group B Strep |
9 |
11 |
10.3 |
21 |
9 |
0 |
|
Meningitis, List Monocytogenes |
6 |
3 |
4.3 |
7 |
0 |
0 |
|
Meningitis, Meningococcal |
27 |
24 |
27 |
41 |
39 |
1 |
|
Meningitis, other |
32 |
55 |
41.3 |
110 |
52 |
2 |
|
Meningitis, Strep Pneumoniae |
71 |
65 |
63.7 |
112 |
38 |
1 |
|
Meningococcemia, disseminated |
43 |
47 |
48 |
80 |
44 |
3 |
|
Mercury Poisoning |
2 |
7 |
3 |
11 |
2 |
0 |
|
Mumps |
2 |
2 |
4.3 |
4 |
2 |
0 |
|
Neurotoxic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
|
Pertussis |
53 |
35 |
37 |
48 |
14 |
1 |
|
Plague, Bubonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Plague, Pneumonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Psittacosis |
0 |
0 |
0.3 |
3 |
0 |
0 |
|
Q Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Human Rabies |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rocky Mountain Spotted Fever |
2 |
0 |
1 |
1 |
2 |
0 |
|
Rubella |
0 |
2 |
1.7 |
2 |
1 |
0 |
|
Rubella, Congenital |
0 |
1 |
0.3 |
1 |
0 |
0 |
|
Salmonellosis |
1316 |
1249 |
1253.7 |
2755 |
1346 |
96 |
|
Shigellosis |
833 |
783 |
954.3 |
1292 |
466 |
30 |
|
Smallpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GISA/VISA) |
0 |
0 |
0 |
0 |
0 |
0 |
|
Staphylococcus Aureus (GRSA/VRSA) |
0 |
0 |
0 |
0 |
0 |
0 |
|
Streptococcal Disease, Invasive Group A |
38 |
74 |
46.7 |
146 |
103 |
4 |
|
Streptococcus Pneumoniae, Invasive |
351 |
633 |
424.3 |
1147 |
577 |
9 |
|
Tetanus |
2 |
0 |
1.3 |
1 |
3 |
0 |
|
Toxoplasmosis |
9 |
6 |
7.3 |
12 |
18 |
4 |
|
Trichinosis |
1 |
0 |
0.3 |
1 |
0 |
0 |
|
Tularemia |
0 |
0 |
0 |
0 |
0 |
0 |
|
Typhoid Fever |
21 |
6 |
12.3 |
12 |
4 |
0 |
|
Vibrio Alginolyticus |
6 |
7 |
5.3 |
15 |
2 |
0 |
|
Vibrio Cholerae Type 01 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Vibrio Cholerae Non-01 |
7 |
4 |
5.7 |
4 |
4 |
0 |
|
Vibrio Fluvialis |
3 |
1 |
2.7 |
2 |
2 |
0 |
|
Vibrio Hollisae |
4 |
3 |
3.3 |
3 |
0 |
0 |
|
Vibrio Mimicus |
1 |
2 |
2 |
2 |
1 |
0 |
|
Vibrio, other |
2 |
0 |
1 |
2 |
0 |
0 |
|
Vibrio Parahaemolyticus |
8 |
7 |
15.7 |
16 |
7 |
0 |
|
Vibrio Vulnificus |
10 |
3 |
9.3 |
13 |
7 |
1 |
|
Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |
* The column of data representing the "3-year average to week ##" is the average of years 1998, 1999 and 2000 cases to the current listed week (##).